Antiprolactinemic approach in the treatment of metastatic breast cancer: a phase II study of polyneuroendocrine therapy with LHRH-analogue, tamoxifen and the long-acting antiprolactinemic drug cabergoline
Lissoni, P, Vaghi, M, Villa, S, Bodraska, A, Cerizza, L, Tancini, G, Gardani, G S
Published in Anticancer research (01.01.2003)
Get more information
Published in Anticancer research (01.01.2003)
Journal Article